Surfactant Protein A Suppresses Progression Of Human Lung Adenocarcinoma In An Experimental Lung Metastasis Model

atsushi mitsuhasi, Saburo Sone(Io Therapeutics (United States)), Yasuhiko Nishioka(Tokushima University), Makoto Tobiume(Tokushima University), Hisatsugu Goto(Tokushima University), Van The Trung(Tokushima University), Joe Rae Wright, Seidai Sato(Tokushima University), Soji Kakiuchi(Tokushima Prefectural Central Hospital), Takuya Kuramoto(Tokushima University), Atsuro Saijo(Tokushima University), Kenji Otsuka(Tokushima University)
Unknown
May 1, 2011
10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a5122
Cited by 0

Related Papers

Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
Expression profiles of non-small cell lung cancers on cDNA microarrays: Identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs
|Oncogene|2003|324
Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa, ZD1839)
|Human Molecular Genetics|2004|175
The Neuromedin U-Growth Hormone Secretagogue Receptor 1b/Neurotensin Receptor 1 Oncogenic Signaling Pathway as a Therapeutic Target for Lung Cancer
|Cancer Research|2006|134
Plakophilin 3 Oncogene as Prognostic Marker and Therapeutic Target for Lung Cancer
|Cancer Research|2005|124